MENU

IKT Inhibikase Therapeutics Forecast, Technical & Fundamental Analysis

Inhibikase Therapeutics Inc a clinical-stage pharmaceutical company developing therapeutics to modify the course of cardiopulmonary diseases, namely, Pulmonary Arterial Hypertension (PAH), in which aberrant signaling through type III receptor tyrosine kinases, including platelet derived growth factor receptors and a stem cell factor receptor, known as c-Kit, has been implicated... Show more

IKT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
IKT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

IKT is expected to report earnings to rise 8.30% to -10 cents per share on August 17

Inhibikase Therapeutics IKT Stock Earnings Reports
Q2'26
Est.
$-0.11
Q1'26
Beat
by $0.07
Q4'25
Beat
by $0.08
Q3'25
Beat
by $0.01
Q2'25
Beat
by $0.01
The last earnings report on May 12 showed earnings per share of -10 cents, beating the estimate of -17 cents. With 424.72K shares outstanding, the current market capitalization sits at 220.49M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
1000 N. West Street
Phone
+1 302 295-3800
Employees
35
Web
https://www.inhibikase.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HSMVX15.470.20
+1.31%
Hartford Small Cap Value R6
OISVX16.170.14
+0.87%
Optimum Small-Mid Cap Value Instl
LCEAX19.440.12
+0.62%
Invesco Diversified Dividend A
INSLX36.020.19
+0.53%
Invesco International Small-Mid Com R5
FCGPX21.770.11
+0.51%
NYLI PineStone Global Equity Class P

IKT and Stocks

Correlation & Price change

A.I.dvisor tells us that IKT and VYGR have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IKT and VYGR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IKT
1D Price
Change %
IKT100%
N/A
VYGR - IKT
32%
Poorly correlated
+1.16%
VIR - IKT
31%
Poorly correlated
+1.06%
SYRE - IKT
31%
Poorly correlated
+0.02%
BNTC - IKT
31%
Poorly correlated
+1.18%
ZLAB - IKT
31%
Poorly correlated
-3.23%
More
Inhibikase Therapeutics (IKT) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com